Robert Alexander is the founder of Allakos. Allakos has raised $32M in total funding. Latest round: Series A. Backed by Novo Ventures.
Robert Alexander, PhD, is the founder and CEO of Allakos, a clinical-stage biotechnology company established in 2012. He led the company from its Series A financing through its public listing in July 2018, and it was later acquired by Concentra Biosciences.
Full founder directory · Investor directory · Company funding database · Fundraising library